October 19, 2021

Deciliiter.ne

Breaking News Breaf

Diabetes Association Celebrates 100th Anniversary of Insulin Discovery


Dr. Saud Al-Sefri, a consultant of diabetes and endocrinology at the Armed Forces Hospitals in Al-Hada and Taif and Vice President of the Saudi Diabetes Association, confirmed that the association is making great efforts in raising awareness and health education for various segments of society in the Kingdom about diabetes and how to live with it, and avoiding its dangerous complications by patients, as well as how to prevent Regarding the healthy, the ambassador called on the media and the media to cooperate with the association and other health sectors in order to deliver awareness messages aimed at curbing the alarming spread of diabetes.

Al-Safi’s statements came during a press conference organized by the association in the Riyadh Hall in the Foco Hotel in Riyadh on the sidelines of the scientific symposium held to celebrate the 100th anniversary of the discovery of insulin, which was attended by a number of officials and health and medical leaders of the Ministry of Health and the public and private medical sectors, in addition to a large number of doctors And health professionals and practitioners from different regions of the Kingdom, led by the Assistant Undersecretary of the Ministry of Health for Paramedical Services, the founding president of the Saudi Society of Clinical Pharmacy, Prof. Dr. Ahmed Al-Judaya, and Dimitri Levadas, President and CEO of Laila Pharmaceutical Industries in the Kingdom.

During the press conference, Dr. Saud Al-Sefri answered journalists’ questions about insulin and its importance for diabetics, stressing that the drug, which has become a medical icon and achieved a therapeutic revolution in the world of diabetes, has gone through several major development stages during the past 100 years, from the beginning of its production until now.. Doctors have worked And researchers are actively developing it through laboratory and laboratory experiments until they were able to reach this advanced stage, which has already contributed to the treatment of type 1 and type 2 diabetes, and it has become an effective treatment for many patients so that they can enjoy a better healthy life.

Al-Sefri added that despite the importance of studies and scientific research conducted by scientists from various universities and research centers in the world, the most prominent of which was the research of stem cell transplantation “beta cells”, which, if successful, will work to produce “insulin” inside the pancreas, but the current insulin drug It is still the most effective drug in the treatment of type 1 and type 2 diabetes.

Al-Safari warned of the danger of a large segment of society continuing to follow wrong behaviors and lifestyles in their lives, whether in terms of food, eating fast food saturated with fat and calories, or not exercising, which inevitably leads to obesity, especially among children and adolescents, and thus diabetes and its fatal complications. .

The Vice-President of the Saudi Diabetes Association confirmed that the Kingdom has become one of the first countries in the world in the incidence of diabetes, as recently published statistics showed that the proportion of people with diabetes ranges between 17 and 18% of the total population, and this percentage is considered very large and dangerous.

For his part, Dmitriy Levadas said: “We are proud to celebrate with the Saudi Diabetes Association the 100th anniversary of the discovery of insulin as we reaffirm our commitment to our future in Saudi Arabia, and Lilly’s commitment to continue investing time and resources in finding better solutions for the hundreds of millions of people suffering from diabetes.”

He added: Today, as we celebrate this achievement, we remain committed to providing innovative treatments to patients around the world and in the Kingdom of Saudi Arabia through the recently concluded Memorandum of Understanding with the Saudi Chemical Holding Company through its pharmaceutical sector represented by Aja Pharmaceutical Industries, and we affirm our commitment to the vision of 2030 and develop local healthcare capabilities in the Kingdom by strengthening our local footprint and helping patients.